The Ghana Medical Trust Fund (GMTF) has begun strategic engagements with global pharmaceutical partners as it prepares to roll out direct support for patients across the country. As part of these efforts, the Fund is engaging Novartis to ensure that Ghanaians can access quality medicines more quickly and at a lower cost. Officials of the Ghana Medical Trust Fund met with the Novartis team on Tuesday afternoon to begin detailed conversations on the scope and structure of the proposed partnership. Reaffirming its mission, the Ghana Medical Trust Fund said it remains committed to compassionate, people-centred healthcare delivery. “At the Ghana Medical Trust Fund, we care,” the statement said, adding that the initiative reflects the broader vision of providing timely, affordable and quality healthcare support to Ghanaians — a commitment the Fund describes as Mahama Cares.